Mus vs Saint Lucia: HIV-positive TB patients on ART (antiretroviral therapy)
Mus
100.0%
in 2024
Saint Lucia
100.0%
in 2019
Mus rank
1st
Saint Lucia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Mus
- Saint Lucia
How they compare
Mus currently reports 100.0% against 100.0% in Saint Lucia, a difference of 0.0%.
The two have swapped places 4 times across 11 shared years of data; in 2007 it was Saint Lucia ahead.
Mus ranks 1st and Saint Lucia ranks 1st of 2 regions.
Across the 2 decades both report, Mus averaged higher in 1 and Saint Lucia in 1.
Head to head by decade
| Decade | Mus | Saint Lucia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 69.0% | 50.0% | 19.0% | Mus |
| 2010s | 85.9% | 93.8% | 7.9% | Saint Lucia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Mus or Saint Lucia?
- Mus, at 100.0% against 100.0% in Saint Lucia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Mus and Saint Lucia?
- 0.0%, with Mus ahead.
- How many years of comparable data are there for Mus and Saint Lucia?
- 11 years are reported by both, from 2007 to 2019.
- How do Mus and Saint Lucia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Mus ranks 1st and Saint Lucia ranks 1st of 2 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.